Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · Urology

No studies found 1 · 20%GRADE not reported 0 · 0%Very low 2 · 40%Low 1 · 20%Moderate 1 · 20%High 0 · 0%

Treatment discontinuation · post‐prostatectomy erectile dysfunction (long‐term)

Scheduled PDE5I showed no clear difference in treatment discontinuation compared with on demand placebo or no treatment (moderate certainty).

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
RR 1.12 [0.85, 1.48]
1 study · 420 participants
Moderate

Treatment discontinuation · post‐prostatectomy erectile dysfunction (short‐term)

Scheduled PDE5I showed no clear difference in treatment discontinuation compared with on demand PDE5I (low certainty).

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
RR 1.35 [0.85, 2.12]
1 study · 282 participants
Low

Treatment discontinuation · post‐prostatectomy erectile dysfunction (long‐term)

It is very uncertain whether scheduled PDE5I changes treatment discontinuation compared with on demand PDE5I (very low certainty).

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
RR 1.09 [0.86, 1.38]
3 studies · 612 participants
Very low

Treatment discontinuation · post‐prostatectomy erectile dysfunction (short‐term)

The review found no eligible studies for this question.

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment discontinuation · post‐prostatectomy erectile dysfunction (short‐term)

It is very uncertain whether scheduled PDE5I changes treatment discontinuation compared with on demand placebo or no treatment (very low certainty).

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
RR 0.98 [0.72, 1.34]
3 studies · 443 participants
Very low